Q4 2021 Collegium Pharmaceutical Inc Earnings Call Transcript
Greetings, and welcome to the Collegium Pharmaceuticals' Fourth Quarter and Full Year 2021 Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the call over to Alex Dasalla, Head of Investor Relations and Corporate Communications.
Thank you, operator. Welcome to Collegium Pharmaceuticals' fourth quarter 2021 earnings conference call. This is Alex Dasalla, Head of Investor Relations and Corporate Communications at Collegium Pharmaceutical. I'm joined today by Joe Ciaffoni, our Chief Executive Officer; Colleen Tupper, our Chief Financial Officer; and Scott Dreyer, our Chief Commercial Officer. Joe and Colleen will share some prepared remarks, and then we will take your questions.
Before we begin today's call, we want to remind participants that none of the information presented today is intended to be promotional, and that any forward-looking statements made today are made pursuant to the safe harbor provision of the Private
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |